Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1961 1
1964 2
1966 1
1967 2
1968 1
1969 1
1973 1
1980 1
1994 1
1995 3
1996 3
1997 4
1998 13
1999 7
2000 5
2001 5
2002 3
2003 11
2004 6
2005 15
2006 10
2007 7
2008 8
2009 9
2010 15
2011 15
2012 15
2013 23
2014 12
2015 12
2016 16
2017 12
2018 15
2019 11
2020 11
2021 11
2022 14
2023 13
2024 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

289 results

Results by year

Filters applied: . Clear all
Page 1
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update.
Fanouriakis A, Kostopoulou M, Andersen J, Aringer M, Arnaud L, Bae SC, Boletis J, Bruce IN, Cervera R, Doria A, Dörner T, Furie RA, Gladman DD, Houssiau FA, Inês LS, Jayne D, Kouloumas M, Kovács L, Mok CC, Morand EF, Moroni G, Mosca M, Mucke J, Mukhtyar CB, Nagy G, Navarra S, Parodis I, Pego-Reigosa JM, Petri M, Pons-Estel BA, Schneider M, Smolen JS, Svenungsson E, Tanaka Y, Tektonidou MG, Teng YO, Tincani A, Vital EM, van Vollenhoven RF, Wincup C, Bertsias G, Boumpas DT. Fanouriakis A, et al. Among authors: mok cc. Ann Rheum Dis. 2024 Jan 2;83(1):15-29. doi: 10.1136/ard-2023-224762. Ann Rheum Dis. 2024. PMID: 37827694
Systemic lupus erythematosus.
Hoi A, Igel T, Mok CC, Arnaud L. Hoi A, et al. Among authors: mok cc. Lancet. 2024 May 25;403(10441):2326-2338. doi: 10.1016/S0140-6736(24)00398-2. Epub 2024 Apr 17. Lancet. 2024. PMID: 38642569 Review.
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis.
Furie R, Rovin BH, Houssiau F, Malvar A, Teng YKO, Contreras G, Amoura Z, Yu X, Mok CC, Santiago MB, Saxena A, Green Y, Ji B, Kleoudis C, Burriss SW, Barnett C, Roth DA. Furie R, et al. Among authors: mok cc. N Engl J Med. 2020 Sep 17;383(12):1117-1128. doi: 10.1056/NEJMoa2001180. N Engl J Med. 2020. PMID: 32937045 Clinical Trial.
The CD6/ALCAM pathway promotes lupus nephritis via T cell-mediated responses.
Chalmers SA, Ayilam Ramachandran R, Garcia SJ, Der E, Herlitz L, Ampudia J, Chu D, Jordan N, Zhang T, Parodis I, Gunnarsson I, Ding H, Shen N, Petri M, Mok CC, Saxena R, Polu KR, Connelly S, Ng CT, Mohan C, Putterman C. Chalmers SA, et al. Among authors: mok cc. J Clin Invest. 2022 Jan 4;132(1):e147334. doi: 10.1172/JCI147334. J Clin Invest. 2022. PMID: 34981775 Free PMC article.
Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups.
Wang YF, Zhang Y, Lin Z, Zhang H, Wang TY, Cao Y, Morris DL, Sheng Y, Yin X, Zhong SL, Gu X, Lei Y, He J, Wu Q, Shen JJ, Yang J, Lam TH, Lin JH, Mai ZM, Guo M, Tang Y, Chen Y, Song Q, Ban B, Mok CC, Cui Y, Lu L, Shen N, Sham PC, Lau CS, Smith DK, Vyse TJ, Zhang X, Lau YL, Yang W. Wang YF, et al. Among authors: mok cc. Nat Commun. 2021 Feb 3;12(1):772. doi: 10.1038/s41467-021-21049-y. Nat Commun. 2021. PMID: 33536424 Free PMC article.
Efficacy and Safety of Belimumab in Patients With Lupus Nephritis: Subgroup Analyses of a Phase 3 Randomized Trial in the East Asian Population.
Yu X, Chen N, Xue J, Mok CC, Bae SC, Peng X, Chen W, Ren H, Li X, Noppakun K, Gilbride JA, Green Y, Ji B, Liu C, Madan A, Okily M, Tang CH, Roth DA. Yu X, et al. Among authors: mok cc. Am J Kidney Dis. 2023 Mar;81(3):294-306.e1. doi: 10.1053/j.ajkd.2022.06.013. Epub 2022 Sep 2. Am J Kidney Dis. 2023. PMID: 36058429 Free article. Clinical Trial.
Editorial: Immune Monitoring Responses in Renal Autoimmune Diseases.
Teng YKO, Pusey CD, Vaglio A, Mok CC, van Kooten C. Teng YKO, et al. Among authors: mok cc. Front Immunol. 2021 Jun 29;12:722791. doi: 10.3389/fimmu.2021.722791. eCollection 2021. Front Immunol. 2021. PMID: 34267765 Free PMC article. No abstract available.
OMERACT systemic lupus erythematosus domain survey.
Nielsen W, Strand V, Simon L, Pinsker E, Bonilla D, Morand E, Thumboo J, Aringer M, Mosca M, Bruce I, Parodis I, Kim A, Desai M, Enman Y, Shea B, Wallace DJ, Chaichian Y, Navarra S, Aranow C, Mackay M, Trotter K, Tayer-Shifman OE, Duarte-García A, Shan Tam L, Ugarte-Gil MF, Pons-Estel GJ, Reynolds JA, Nikpour M, Hoi A, Romero-Diaz J, Aggarwal A, Mok CC, Fujio K, Ramsey-Goldman R, Gladman DD, Arnaud L, Bultink IEM, Ruiz-Irastorza G, Inês LS, Appenzeller S, Dobrowolski C, Clarke AE, Kamen DL, Barraclough M, Tani C, Gómez-Puerta JA, Werth VP, Katz P, Nowrouzi-Kia B, Johnson SR, Drucker AM, Touma Z; OMERACT SLE Working Group. Nielsen W, et al. Among authors: mok cc. Semin Arthritis Rheum. 2024 Oct;68:152520. doi: 10.1016/j.semarthrit.2024.152520. Epub 2024 Jul 24. Semin Arthritis Rheum. 2024. PMID: 39106780
289 results